Bowlby J Attachment and Loss Volume I: Attachment. 2nd ed. New York: Basic Books Inc; 1982
Bowlby J Attachment and Loss Volume II: Separation. Anxiety and Anger. New York: Basics Books, Inc; 1973.
BOWLBY J The nature of the child's tie to his mother. Int J Psychoanal. 1958 Sep-Oct;39(5):350-73.
Cranley MS Development of a tool for the measurement of maternal attachment during pregnancy. Nurs Res. 1981 Sep-Oct;30(5):281-4.
Kapçi EG, Küçüker S [The parental bonding instrument: evaluation of psychometric properties with Turkish university students]. Turk Psikiyatri Derg. 2006 Winter;17(4):286-95. Turkish.
Noriuchi M, Kikuchi Y, Senoo A The functional neuroanatomy of maternal love: mother's response to infant's attachment behaviors. Biol Psychiatry. 2008 Feb 15;63(4):415-23. Epub 2007 Aug 7.
Pirdal H, Yalçin BM, Ünal M Knowledge levels of pregnants on their pregnancy and the related factors. Turkish Journal of Family Practice. 2016;20(1):7-15.
Rodriguez CM, Tucker MC Behind the cycle of violence, beyond abuse history: a brief report on the association of parental attachment to physical child abuse potential. Violence Vict. 2011;26(2):246-56.
Evaulation of Maternal-infant Bonding in Postpartum Period of Healthy Women With Family Medicine Perspective
Interventional studies are often prospective and are specifically tailored to evaluate direct impacts of treatment or preventive measures on disease.
Observational studies are often retrospective and are used to assess potential causation in exposure-outcome relationships and therefore influence preventive methods.
Expanded access is a means by which manufacturers make investigational new drugs available, under certain circumstances, to treat a patient(s) with a serious disease or condition who cannot participate in a controlled clinical trial.
Clinical trials are conducted in a series of steps, called phases - each phase is designed to answer a separate research question.
Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.
